These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20833617)
1. Evaluation of nonprescription syringe sales in San Francisco. Rose VJ; Raymond HF J Am Pharm Assoc (2003); 2010; 50(5):595-9. PubMed ID: 20833617 [TBL] [Abstract][Full Text] [Related]
2. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley. Pollini RA J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658 [TBL] [Abstract][Full Text] [Related]
3. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. Cooper EN; Dodson C; Stopka TJ; Riley ED; Garfein RS; Bluthenthal RN J Urban Health; 2010 Jul; 87(4):543-52. PubMed ID: 20549568 [TBL] [Abstract][Full Text] [Related]
4. Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010. Lutnick A; Cooper E; Dodson C; Bluthenthal R; Kral AH J Urban Health; 2013 Apr; 90(2):276-83. PubMed ID: 22718357 [TBL] [Abstract][Full Text] [Related]
5. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621 [TBL] [Abstract][Full Text] [Related]
6. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Singer M; Baer HA; Scott G; Horowitz S; Weinstein B Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813 [TBL] [Abstract][Full Text] [Related]
7. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices. Wright-De Agüero L; Weinstein B; Jones TS; Miles J J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632 [TBL] [Abstract][Full Text] [Related]
8. Nonprescription syringe sales: Resistant pharmacists' attitudes and practices. Chiarello E Drug Alcohol Depend; 2016 Sep; 166():45-50. PubMed ID: 27423213 [TBL] [Abstract][Full Text] [Related]
9. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993. Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288 [TBL] [Abstract][Full Text] [Related]
10. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. Gleghorn AA; Gee G; Vlahov D J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S89-93. PubMed ID: 9663630 [TBL] [Abstract][Full Text] [Related]
11. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention. Zaller ND; Yokell MA; Apeakorang N; Gaggin J; Case P J Health Care Poor Underserved; 2012 Aug; 23(3):1310-26. PubMed ID: 24212176 [TBL] [Abstract][Full Text] [Related]
12. What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey. Klein SJ; Harris-Valente K; Candelas AR; Radigan M; Narcisse-Pean M; Tesoriero JM; Birkhead GS J Urban Health; 2001 Dec; 78(4):679-89. PubMed ID: 11796814 [TBL] [Abstract][Full Text] [Related]
13. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. Coffin PO; Linas BP; Factor SH; Vlahov D J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317 [TBL] [Abstract][Full Text] [Related]
14. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA. Siddiqui SS; Armenta RF; Evans JL; Yu M; Cuevas-Mota J; Page K; Davidson P; Garfein RS Int J Drug Policy; 2015 Nov; 26(11):1150-7. PubMed ID: 26252980 [TBL] [Abstract][Full Text] [Related]
15. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015. Stopka TJ; Donahue A; Hutcheson M; Green TC J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540 [TBL] [Abstract][Full Text] [Related]
16. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. Riley ED; Kral AH; Stopka TJ; Garfein RS; Reuckhaus P; Bluthenthal RN J Urban Health; 2010 Jul; 87(4):534-42. PubMed ID: 20526690 [TBL] [Abstract][Full Text] [Related]
17. Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: A systematic review. Gionfriddo MR; Owens KM; Leist SE; Schrum LT; Covvey JR J Am Pharm Assoc (2003); 2023; 63(5):1472-1489.e3. PubMed ID: 37429389 [TBL] [Abstract][Full Text] [Related]
18. Injection drug users report good access to pharmacy sale of syringes. Reich W; Compton WM; Horton JC; Cottler LB; Cunningham-Williams RM; Booth R; Singer M; Leukefeld C; Fink J; Stopka TJ; Corsi KF; Tindall MS J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S68-72. PubMed ID: 12489619 [TBL] [Abstract][Full Text] [Related]
19. Pharmacy nonprescription syringe distribution and HIV/AIDS: a review. Janulis P J Am Pharm Assoc (2003); 2012; 52(6):787-97. PubMed ID: 23229966 [TBL] [Abstract][Full Text] [Related]
20. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. Lewis BA; Koester SK; Bush TW J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S46-51. PubMed ID: 12489615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]